A federal judge found that Mr. Shkreli violated state and federal antitrust laws by trying to maintain a monopoly over a lifesaving drug and must pay back the excess profits.
Source: New York Times
Martin Shkreli Barred From Drug Industry and Must Repay $64.6 Million
Published in Antitrust Laws and Competition Issues, Cote, Denise, Decisions and Verdicts, Drugs (Pharmaceuticals), Prices (Fares, Fees and Rates), Shkreli, Martin (1983- ) and Vyera Pharmaceuticals LLC
More from Antitrust Laws and Competition IssuesMore posts in Antitrust Laws and Competition Issues »
More from Cote, DeniseMore posts in Cote, Denise »
More from Decisions and VerdictsMore posts in Decisions and Verdicts »
- Judge Tells U.S. to Help Bring Back Deported Venezuelans or Allow Legal Challenges
- Mistrial in Case of N.Y. Official Charged With Working for China
- In Trump’s Justice Dept., Failing in Court Might Be Better Than Bucking the Boss
- Trump Commuted David Gentile’s Sentence. His Victims Are Seething.
- Prosecutors Drop Murder Case Against Man Who Served More Than 25 Years
More from Drugs (Pharmaceuticals)More posts in Drugs (Pharmaceuticals) »
More from Prices (Fares, Fees and Rates)More posts in Prices (Fares, Fees and Rates) »
Be First to Comment